Published in Life Sci on December 30, 1985
Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen. Proc Natl Acad Sci U S A (1988) 0.92
Identification of serum monocyte chemoattractant protein-1 and prolactin as potential tumor markers in hepatocellular carcinoma. PLoS One (2013) 0.91
Testing electromagnetic fields for potential carcinogenic activity: a critical review of animal models. Environ Health Perspect (1997) 0.85
Combination therapy targeting integrins reduces glioblastoma tumor growth through antiangiogenic and direct antitumor activity and leads to activation of the pro-proliferative prolactin pathway. Mol Cancer (2013) 0.84
Prolactin signaling enhances colon cancer stemness by modulating Notch signaling in a Jak2-STAT3/ERK manner. Carcinogenesis (2013) 0.82
Correlation between serum prolactin levels and hepatocellular tumorigenesis induced by 3'-methyl-4-dimethylaminoazobenzene in mice. Br J Cancer (1995) 0.81
Does hyperprolactinemia affect hepatic regeneration independent of sex steroids? J Lab Clin Med (1988) 0.77
Human growth hormone and human prolactin function as autocrine/paracrine promoters of progression of hepatocellular carcinoma. Oncotarget (2016) 0.75
Orthotopic liver transplantation in ninety-three patients. Surg Gynecol Obstet (1976) 8.11
Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc (1974) 5.53
Cyclophosphamide and whole organ transplantation in human beings. Surg Gynecol Obstet (1971) 5.24
Biliary complications after liver transplantation: with special reference to the biliary cast syndrome and techniques of secondary duct repair. Surgery (1977) 4.08
The origin, hormonal nature, and action of hepatotrophic substances in portal venous blood. Surg Gynecol Obstet (1973) 3.84
Effects of insulin, glucagon, and insuling/glucagon infusions on liver morphology and cell division after complete portacaval shunt in dogs. Lancet (1976) 3.74
Hepatic trisegmentectomy and other liver resections. Surg Gynecol Obstet (1975) 3.66
Right trisegmentectomy for hepatic neoplasms. Surg Gynecol Obstet (1980) 3.64
Delayed biliary duct obstruction after orthotopic liver transplantation. Surgery (1972) 3.26
Amine synthesis in regenerating rat liver: extremely rapid turnover of ornithine decarboxylase. Mol Pharmacol (1969) 3.21
Iatrogenic alterations of immunologic surveillance in man and their influence on malignancy. Transplant Rev (1971) 2.94
Effects of intermittent androgen suppression on androgen-dependent tumors. Apoptosis and serum prostate-specific antigen. Cancer (1993) 2.56
Acute neurological complications after liver transplantation with particular reference to intraoperative cerebral air embolus. Ann Surg (1978) 2.48
Portal diversion for the treatment of glycogen storage disease in humans. Ann Surg (1973) 2.44
Mortality of gasworkers - final report of a prospective study. Br J Ind Med (1972) 2.31
Heterologous antilymphocyte glubulin, histoincompatiblity matching, and human renal homotransplantation. Surg Gynecol Obstet (1968) 2.23
Immunosuppression, liver injury, and hepatitis in renal, hepatic, and cardiac homograft recipients: with particular reference to the Australia antigen. Ann Surg (1971) 2.14
RAD53, DUN1 and PDS1 define two parallel G2/M checkpoint pathways in budding yeast. EMBO J (1999) 2.05
Sulfasalazine, a potent suppressor of lymphoma growth by inhibition of the x(c)- cystine transporter: a new action for an old drug. Leukemia (2001) 2.03
Tandem quadrupole Fourier-transform mass spectrometry of oligopeptides and small proteins. Proc Natl Acad Sci U S A (1987) 1.96
Color Doppler imaging and spectral analysis of the optic nerve vasculature in glaucoma. Am J Ophthalmol (1995) 1.94
Infections in recipients of liver homografts. N Engl J Med (1968) 1.92
The influence of portal blood upon lipid metabolism in normal and diabetic dogs and baboons. Surg Gynecol Obstet (1975) 1.91
Urological complications in 216 human recipients of renal transplants. Ann Surg (1970) 1.90
Recovery from "hepatorenal syndrome" after orthotopic liver transplantation. N Engl J Med (1973) 1.85
Fungus infections after liver transplantation. Ann Surg (1977) 1.81
Liver allograft. Its use in chronic active hepatitis with macronodular cirrhosis, hepatitis B surface antigen. Arch Surg (1979) 1.80
Cyclophosphamide and human organ transplantation. Lancet (1971) 1.77
Alopecia, ascites, and incomplete regeneration after 85 to 90 per cent liver resection. Am J Surg (1975) 1.72
Coupling high-pressure MALDI with ion mobility/orthogonal time-of-flight mass spectrometry. Anal Chem (2000) 1.69
Portacaval shunt in hyperlipoproteinaemia. Lancet (1973) 1.66
Determination of the protein composition of the occlusion-derived virus of Autographa californica nucleopolyhedrovirus. Proc Natl Acad Sci U S A (2003) 1.62
Intraportal insulin protects from the liver injury of portacaval shunt in dogs. Lancet (1975) 1.55
Liver replacement for alpha1-antitrypsin deficiency. Surgery (1977) 1.53
Proteolysis in mixed organic-aqueous solvent systems: applications for peptide mass mapping using mass spectrometry. Anal Chem (2001) 1.53
Polyamines as markers of response and disease activity in cancer chemotherapy. Cancer Res (1977) 1.52
A trial with heterologous antilymphocyte globulin in man. Transplant Proc (1969) 1.51
Clinical and pathologic observations after orthotopic transplantation of the human liver. Surg Gynecol Obstet (1969) 1.51
Abdominal wall hernias in patients with abdominal aortic aneurysmal versus aortoiliac occlusive disease. Am J Surg (1995) 1.50
Infections complicating orthotopic liver transplantation: a study emphasizing graft-related septicemia. Arch Surg (1976) 1.50
Prolactin receptors on human T and B lymphocytes: antagonism of prolactin binding by cyclosporine. J Immunol (1985) 1.47
The dynamics of synthesis and degradation of polyamines in normal and regenerating rat liver and brain. J Biol Chem (1970) 1.47
Identification of the naturally occurring flavin of nitroalkane oxidase from fusarium oxysporum as a 5-nitrobutyl-FAD and conversion of the enzyme to the active FAD-containing form. J Biol Chem (1997) 1.42
Use of a U tube in the treatment of biliary disease. Surg Gynecol Obstet (1976) 1.40
Color Doppler imaging in patients with asymmetric glaucoma and unilateral visual field loss. Am J Ophthalmol (1996) 1.37
Hepatic ischemia, caused by celiac axis compression, complicating pancreaticoduodenectomy. Ann Surg (1993) 1.36
Prolactin receptors on human lymphocytes and their modulation by cyclosporine. Biochem Biophys Res Commun (1984) 1.33
The effect of diabetes mellitus on portal blood hepatotrophic factors in dogs. Surg Gynecol Obstet (1975) 1.33
Increased polyamine concentrations in the urine of human cancer patients. Nat New Biol (1971) 1.32
Purification and characterization of S-adenosyl-L-methionine decarboxylase from rat liver. Biochemistry (1972) 1.32
Current policies in hepatic transplantation: candidacy of patients with alcoholic liver disease or preformed antidonor antibodies and a reappraisal of biliary duct reconstruction. Ann N Y Acad Sci (1975) 1.30
The roles of the polyamines, putrescine, spermidine, and spermine in normal and malignant tissues. Life Sci (1973) 1.30
Radiofrequency ablation followed by resection of malignant liver tumors. Am J Surg (1999) 1.30
Cyclic AMP, cyclic AMP-dependent protein kinase, and the regulation of gene expression. Life Sci (1977) 1.29
Posttranslational modification of ornithine decarboxylase by its product putrescine. Biochem Biophys Res Commun (1981) 1.29
Polyamine biosynthesis and accumulation during the G1 to S phase transition. J Cell Physiol (1977) 1.26
Liver transplantation of Budd-Chiari syndrome. JAMA (1976) 1.26
Amine synthesis in regenerating rat liver: effect of hypophysectomy and growth hormone on ornithine decarboxylase. Endocrinology (1969) 1.25
Proposed model of major sequential biochemical events of a trophic response. Life Sci (1976) 1.22
Pathology of liver transplantation. Transplantation (1976) 1.21
Clinical relevance of polyamines as biochemical markers of tumor kinetics. Clin Chem (1977) 1.18
On the structure elucidation using ion mobility spectrometry and molecular dynamics. J Phys Chem A (2009) 1.18
Growth hormone induction of ornithine decarboxylase in rat liver. Endocrinology (1970) 1.17
Cell cycle-specific activity of type I and type II cyclic adenosine 3':5'-monophosphate-dependent protein kinases in Chinese hamster ovary cells. J Biol Chem (1976) 1.17
A decade followup in early cases of renal homotransplantation. Ann Surg (1974) 1.16
Metabolism of 2,2',3,3',6,6'-hexachlorobiphenyl and 2,2',4,4',5,5'-hexachlorobiphenyl by human hepatic microsomes. Biochem Pharmacol (1983) 1.16
Ornithine decarboxylase as a biological and pharmacological tool. Pharmacology (1980) 1.16
Urinary polyamines in cancer patients. Cancer Res (1971) 1.15
Polyamines as predictors of success and failure in cancer chemotherapy. Lancet (1975) 1.14
Concanavalin A-stimulated murine splenocytes produce a factor with prolactin-like bioactivity and immunoreactivity. Biochem Biophys Res Commun (1987) 1.13
Clinical liver transplantation. Transplant Rev (1969) 1.13
Hepatic encephalopathy and light and electron micrographic changes of the baboon liver after portal diversion. Ann Surg (1976) 1.11
Ornithine decarboxylase activity: control by cyclic nucleotides. Science (1975) 1.09
Progress in liver transplantation. World J Surg (1977) 1.07
Experimental and theoretical studies of (CsI)n Cs+ cluster ions produced by 355 nm laser desorption ionization. J Phys Chem A (2008) 1.07
Measurement of putrescine, spermidine, and spermine in physiological fluids by use of an amino acid analyzer. Clin Chem (1973) 1.07
Type I and type II cyclic AMP-dependent protein kinase as opposite effectors of lymphocyte mitogenesis. Nature (1977) 1.07
Isolation and characterization of two distinct forms of liver fatty acid binding protein from the rat. Biochim Biophys Acta (1999) 1.06
Detection of Australia antigen by biological assay in 'Au negative' kidney homograft recipients with hepatic dysfunction. Clin Exp Immunol (1972) 1.06
Differential expression of type I and type II cyclic AMP-dependent protein kinases during cell cycle and cyclic AMP-induced growth arrest. Proc Natl Acad Sci U S A (1980) 1.05
Reappraisal of plateau phase in myeloma. Lancet (1980) 1.04
Clinical relevance of polyamines. Crit Rev Clin Lab Sci (1983) 1.04
Polyamine synthesis in rapidly growing tissues. Fed Proc (1970) 1.04
Cyclophosphamide for clinical renal and hepatic transplantation. Transplant Proc (1973) 1.04
Clostridium difficile and cytotoxin in feces of patients with antimicrobial agent-associated pseudomembranous colitis. Infection (1982) 1.04
Regulation of interleukin 2-driven T-lymphocyte proliferation by prolactin. Proc Natl Acad Sci U S A (1990) 1.04
Factors influencing the safety of colostomy closure in the elderly. J Surg Res (1994) 1.02
The relationship between polyamine accumulation and DNA replication in synchronized Chinese hamster ovary cells after heat shock. Cancer Res (1977) 1.01
Putrescine and spermidine biosynthesis in the development of normal and anucleolate mutants of Xenopus laevis. Proc Natl Acad Sci U S A (1971) 1.01
Changes in polyamine metabolism in WI38 cells stimulated to proliferate. Exp Cell Res (1975) 1.00
Indications for orthotopic liver transplantation: with particular reference to hepatomas, biliary atresia, cirrhosis, Wilson's disease and serum hepatitis. Transplant Proc (1971) 1.00
Letter: Follow-up of patient with portacaval shunt for the treatment of hyperlipidaemia. Lancet (1974) 1.00
Fine-tuning the ring-size of metallacyclophanes: a rational approach to molecular pentagons. J Am Chem Soc (2001) 0.99
Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses. J Am Acad Dermatol (1983) 0.99
Reproducibility and quantitation of matrix-assisted laser desorption ionization mass spectrometry: effects of nitrocellulose on peptide ion yields. Biol Mass Spectrom (1993) 0.99
Pro-sterol carrier protein-2: role of the N-terminal presequence in structure, function, and peroxisomal targeting. J Biol Chem (2000) 0.98
Polyamines. (1) Enhanced s-adenosyl-L-methionine decarboxylase in rapid growth systems, and (2) the relationships between polyamine concentration and RNA accumulation. Biochim Biophys Acta (1971) 0.98
Thymectomy and renal homotransplantation. Clin Exp Immunol (1970) 0.98